Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers

被引:15
|
作者
Ragueneau, I
Poirier, JM
Radembino, N
Sao, AB
Funck-Brentano, C
Jaillon, P
机构
[1] St Antoine Univ Hosp, Clin Pharmacol Unit, F-75012 Paris, France
[2] St Antoine Univ Hosp, Dept Pharmacol, F-75012 Paris, France
关键词
digoxin; drug interaction; healthy volunteers; macrogol; 4000; pharmacodynamics; pharmacokinetics;
D O I
10.1046/j.1365-2125.1999.00025.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of this study was to examine the bioequivalence between a single oral dose of digoxin administered alone and with a coadministration of macrogol 4000 (a laxative polymer) in 18 healthy volunteers. Methods This was an open, randomised, two-way cross-over study, with a single dose oral administration of 0.5 mg digoxin administered alone or in combination with macrogol 4000, 20 g day(-1) during 8 days. Pharmacokinetics of digoxin, heart rate and PR ECG interval at rest were assessed. Results Macrogol 4000 coadministration was associated with a 30% decrease of digoxin AUC and a 40% decrease in its C-max (P<0.05). Digoxin t(max) and t(1/2,z) were nor significantly altered. Heart rate and PR interval did not differ during the two therapeutic sequences, digoxin alone and digoxin in combination. Conclusions Macrogol 4000 coadministration interacts with single-dose digoxin pharmacokinetics. This is most likely due to a reduction of the intestinal absorption of digoxin. However, there was no consequence of this interaction on heart rate and AV conduction.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 50 条
  • [31] Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
    Lee, Hae Won
    Kang, Woo Youl
    Jung, Wookjae
    Gwon, Mi-Ri
    Cho, Kyunghee
    Lee, Backhwan
    Seong, Sook Jin
    Yoon, Young-Ran
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (05): : 623 - 631
  • [32] Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
    Yoshiaki Kirigaya
    Masanari Shiramoto
    Tomoko Ishizuka
    Hinako Uchimaru
    Shin Irie
    Manabu Kato
    Takako Shimizu
    Takafumi Nakatsu
    Yasuhiro Nishikawa
    Hitoshi Ishizuka
    BMC Pharmacology and Toxicology, 21
  • [33] Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
    Kirigaya, Yoshiaki
    Shiramoto, Masanari
    Ishizuka, Tomoko
    Uchimaru, Hinako
    Irie, Shin
    Kato, Manabu
    Shimizu, Takako
    Nakatsu, Takafumi
    Nishikawa, Yasuhiro
    Ishizuka, Hitoshi
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [34] Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects
    Bruderer, Shirin
    Okubo, Kaori
    Mukai, Hideya
    Mant, Tim
    Dingemanse, Jasper
    CLINICAL THERAPEUTICS, 2016, 38 (05) : 1228 - 1236
  • [35] Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin
    Yang, Bing-Bing
    Gillespie, Brad
    Smith, Brian
    Smith, William
    Lissmats, Agneta
    Rudebeck, Mattias
    Kullenberg, Torbjorn
    Olsson, Birgitta
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (10) : 1109 - 1118
  • [36] Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants
    Italiano, Domenico
    Spina, Edoardo
    de Leon, Jose
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (11) : 1457 - 1489
  • [37] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Sreeneeranj Kasichayanula
    Ming Chang
    Xiaoni Liu
    Wen-Chyi Shyu
    Steven C. Griffen
    Frank P. LaCreta
    David W. Boulton
    Advances in Therapy, 2012, 29 : 163 - 177
  • [38] Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects
    Kim, Chang Hee
    An, Hyungmi
    Kim, Sung Hye
    Shin, Dongseong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3461 - 3469
  • [39] Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
    Hwang, Inyoung
    Kim, Yun
    Yoo, Hyounggyoon
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, SeungHwan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4493 - 4502
  • [40] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Kasichayanula, Sreeneeranj
    Chang, Ming
    Liu, Xiaoni
    Shyu, Wen-Chyi
    Griffen, Steven C.
    LaCreta, Frank P.
    Boulton, David W.
    ADVANCES IN THERAPY, 2012, 29 (02) : 163 - 177